Navigation Links
Neurochem reports results for third quarter of fiscal 2007
Date:11/7/2007

Neurochem will host a live web conference Thursday November 8, 2007, at

8:30 AM ET.

LAVAL, QC, Nov. 7 /PRNewswire-FirstCall/ - Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) reported results for the third quarter ended September 30, 2007. Effective July 1, 2007, the Company adopted the US dollar as its functional and reporting currency, thus all figures reported are reported in US dollars, unless otherwise specified. The Company reported a net loss of $13,889,000 ($0.29 per share), compared to $16,509,000 ($0.43 per share) for the corresponding period in the previous year. For the nine-month period ended September 30, 2007, the net loss amounted to $65,389,000 ($1.54 per share), compared to $49,458,000 ($1.28 per share) for the same period last year.

The net loss for the nine-month period ended September 30, 2007, includes a non-recurring charge in the second quarter of fiscal 2007 under Canadian GAAP of $10,431,000 relating to the $40 million 5% senior subordinated convertible notes, which were fully converted into common shares during the second quarter of 2007.

Research and development (R&D) expenses amounted to $11,964,000 this quarter compared to $12,890,000 for the same period last year. For the nine-month period, R&D expenses were $43,533,000 compared to $37,546,000 for the corresponding period of the previous year. The increase in the nine-month period compared to the same period the previous year is due to expenses incurred in relation to the development of tramiprosate (ALZHEMED(TM)) primarily in respect of the ongoing Phase III clinical trial in Europe and the North American open-label extension of the Phase III study, as well as the conduct of a QT cardiac status Phase I study. Tramiprosate (ALZHEMED(TM)) is the Company's investigational product candidate for the treatment of Alzheimer's disease (AD).

As at September 30, 2007, the Company had available cash, cash equivalents and marketable securiti
'/>"/>

SOURCE NEUROCHEM INC.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... (PRWEB) March 31, 2015 The American ... events. The schedule for April will include interesting workshops, ... New Student Orientation, 9-11 a.m. April 6, ACTCM welcomes ... Room D at the Pioneer Square Campus located at ... Aid, 12:30-1:30 p.m. April 14, Students will be updated ...
(Date:3/31/2015)... Many people, including the ones with ... and cycling are only for able-bodied participants. , ... Institute aims to change that thinking. , The ... an Adaptive Sports Expo on Saturday, April 11 (10 ... in Hollywood. , The event will showcase a ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 On March 26, ... Go Down the Silicone Slope?” provides a look into the ... filler , and laser treatments . The article suggests ... reality TV stars such as Kim Kardashian and Kylie Jenner ... media are increasingly seen as significant influences on the self-esteem ...
(Date:3/31/2015)... NJ (PRWEB) March 31, 2015 Dr. Russell ... for Advanced Reconstruction. He was recently quoted in an ... caused by lymphatic issues, causing fluid retention and tissue swelling. ... procedure to relieve and / or improve lymphedema symptoms. ... improve or alleviate the symptoms of lymphedema. The goal ...
(Date:3/31/2015)... March 31, 2015 Beckman Coulter is sponsoring ... USP 787: “Subvisible Particulate Matter in Therapeutic Protein Injections”,” an ... new demands in counting particles in liquids, with a focus ... webinar is free to attend and will be broadcast live ... posted a new test for protein-based materials, known as ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces April Event Schedule 2Health News:Memorial Healthcare System's Adaptive Sports Expo Encourages Physically Challenged To Go Beyond Perceived Limitations 2Health News:Cosmetic Surgery: Does Social Media Pressure Young Girls to Get Botox and Fillers? 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 3Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 4Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 3
... ban on junk food in school canteens following a report ... its report// has shown concern about the increasing number of ... out by DDRC in 38 schools showed that one in ... food rampant in the school canteens contributed towards this cause. ...
... the source or inspiration of most new drugs created in the ... work in the natural// products branch of the National Cancer ... all new drugs approved from January 1981 through June 2006 for ... wide range of conditions. ,Only thirty percent of the ...
... the high during weekends. This is attributed to the quality ... patients. This study was conducted by William J. Kostis and ... New Jersey in New Brunswick. ,Kostis ... between the years 1987 and 2002. These were patients suffering ...
... Former Chhattisgarh's chief minister Ajit Jogi was hospitalized here ... arrested in connection// with the murder of Nationalist Congress ... was brought to Raipur at 4.10 a.m. Monday and ... chest pain," Jogi's family sources told IANS. ...
... A new study that was published in Britain indicates that the ... still more than the desired// level. Health experts opine that cardiac ... salt intake. ,According to the report, there is a ... last measured in 2001. Men have cut down their salt intake ...
... hormone that is important in the control of blood pressure ... way to prevent or treat the deadly cancer, according to ... scientists said that in mice treated with the hormone, angiotensin-(1-7), ... not receive the treatment, the tumor size more than doubled. ...
Cached Medicine News:Health News:Drug for Blood Pressure also Treats Lung Cancer 2
(Date:3/31/2015)... PARK, N.C. , March 31, 2015  Dr. ... will be attending the World Orphan Drug Congress in April ... regulatory approval process and orphan drugs below: ... (DTAB) has recommended to the Ministry of Health that if ... country, marketing authorization can be obtained in India ...
(Date:3/31/2015)...  On May 2, 2015 global experts on ... Santa Monica, CA at the 5th ... Pleural Mesothelioma (MPM), a rare form of cancer ... affects the lining of the chest– the pleura. ... Pacific Mesothelioma Center (PMC). ...
(Date:3/31/2015)... BC , March 31, 2015 /CNW/ - T-Bird Pharma ... focused on developing premium quality medical marijuana products and ... Marihuana for Medical Purposes Regulations ( Canada ... received notice from The Corporation of the District of ... approval of the Company,s premises which now allows for ...
Breaking Medicine Technology:Max Neeman to Discuss India's Orphan Drug Regulations at WOD 2015 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 3Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 4T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3
... Bionovo, Inc.,(Nasdaq: BNVI ) announced today that its ... Phase 2 clinical testing after the,successful completion of a ... clinical trial was conducted to identify the maximum,tolerated dose ... of the,company,s novel, oral, anticancer treatment. A total of ...
... MedImmune today announced,that it has initiated a Phase ... healthy children one month to 12 months of age ... is,the most common respiratory infection in infants and can ... is a serious respiratory disease that can have significant ...
Cached Medicine Technology:Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 2Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 3Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 4MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine 2
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
Intermittent catheter - Ready-to-Use Sterile, Enclosed System...
... The VerifyNow (Ultegra) System is ... which measures platelet induced aggregation as ... system consists of an instrument, a ... assay device contains reagents based on ...
... The Model 700 Whole Blood/Optical Lumi-Aggregometer available ... This new Aggregometer measures platelet function on ... blood or optical density in plasma with ... method. The Model 700 Aggregometer also has ...
Medicine Products: